How pharma keeps a trove of drug trials out of public view

A third of the clinical trial results that federal regulators reviewed to approve drugs made by large pharmaceutical companies in 2012 were never publicly reported, according to a new study that grades companies on their transparency. To assemble the report, a handful of dogged researchers pored over thousands of pages of regulatory documents, counting up the number of […]

“The Scourge of Managerialism” – Generic Management, the Manager’s Coup D’Etat, Mission-Hostile Management Rolled Up, as Described by Some Men from Down Under

I now believe that the most important cause of US health care dysfunction, and likely of global health care dysfunction, are the problems in leadership and governance we have often summarized (leadership that is ill-informed, ignorant or hostile to the health care mission and professional values, incompetent, self-interested, conflicted or outright criminal or corrupt, and […]